¿Los medicamentos homeopáticos inducen síntomas en voluntarios aparentemente sanos? Contribución brasileña al debate sobre los estudios patogénicos homeopáticos / Do homeopathic medicines induce symptoms in apparently healthy volunteers? Brazilian contribution to the debate on homeopathic pathogenic studies

La valoración crítica de la seguridad de los medicamentos homeopáticos se ha desarrollado recientemente. Esta cuestión es relevante para la toma de decisiones de los médicos, pacientes y dependencias regulatorias de fármacos. A pesar de la aparente inverosimilitud de la acción de los medicamentos homeopáticos debido a los procesos farmacotécnicos de la dilución y agitación empleados para su preparación, existen reportes en la literatura médica convencional sobre la toxicidad de los medicamentos homeopáticos, incluyendo eventos que aparentemente ponen en riesgo la vida. Las revisiones sistemáticas de estudios clínicos controlados aleatorizados muestran que los medicamentos homeopáticos provocan más efectos adversos que el placebo, aunque leves y transitorios. El establecimiento de un sistema de monitoreo en línea para la recolección de datos sobre los efectos adversos de los medicamentos homeopáticos, herbolarios o convencionales, es relevante para una evaluación no sesgada de la información reunida a partir de los consumidores y proveedores de atención médica.

Critical appraisal of the safety of homeopathic medicines developed recently. This matter is relevant for decision making by doctors, patients and drug regulatory agencies. Despite the apparent implausibility of the action of homeopathic medicines due to the pharmacotechnical processes of dilution and agitation used for their preparation, there are reports in the conventional medical literature on the toxicity of homeopathic medicines, including apparently life-threatening events. Systematic reviews of randomized controlled trials show that homeopathic medicines cause more adverse effects than placebo, albeit mild and transient. Establishing an online monitoring terapéusystem for collection of data on the adverse effects of homeopathic, herbal or conventional medicines is relevant for non-biased assessment of the information gathered from consumers and health care providers.

Estrógeno potenciado en el tratamiento homeopático del dolor pélvico asociado a endometriosis: un estudio aleatorizado, doble ciego, controlado con placebo, de 24 semanas / Potentiated estrogen in the homeopathic treatment of pelvic pain associated with endometriosis: a 24-week randomized, double-blind, placebo-controlled study

Evaluar la eficacia y seguridad del estrógeno potenciado en comparación con el placebo en el tratamiento homeopático del dolor pélvico asociado a endometriosis (EAPP, por sus siglas en inglés). Diseño del estudio: El presente fue un estudio clínico aleatorizado, doble ciego, controlado con placebo, de 24 semanas, el cual incluyó a 50 mujeres de entre 18 y 45 años de edad con diagnóstico de endometriosis infiltrante profunda con base en ultrasonido transvaginal o imágenes de resonancia magnética después de preparación intestinal, así como puntaje ≥ 5 en una escala visual analógica (VAS: rango de 0 a 10 puntos) para el dolor pélvico asociado con la endometriosis. Se administró estrógeno potenciado (12cH, 18cH y 24cH) o placebo dos veces al día por vía oral. La medida principal de resultado fue el cambio en la severidad de los puntajes parcial y global de EAPP (VAS) de la línea basal a la semana 24, determinada como la diferencia en el puntaje medio de cinco modalidades de dolor pélvico crónico (dismenorrea, dispareunia profunda, dolor pélvico no cíclico, dolor intestinal cíclico y/o dolor urinario cíclico). Las medidas secundarias de resultado fueron la diferencia media de puntaje para la calidad de vida evaluada con el Cuestionario de Salud SF-36, los síntomas de depresión en el Inventario de la Depresión de Beck (BDI) y los síntomas de ansiedad en el Inventario de Ansiedad de Beck (BAI). Resultados: El puntaje global de EAPP (VAS: rango de 0 a 50 puntos) se redujo en 12.82 (p < 0.001) en el grupo tratado con estrógeno potenciado de la línea basal a la semana 24. El grupo que utilizó estrógeno potenciado también presentó una reducción en el puntaje parcial (VAS: rango de 0 a 10 puntos) en tres modalidades de EAPP: dismenorrea (3.28; p < 0.001), dolor pélvico no cíclico (2.71; p = 0.009) y dolor intestinal cíclico (3.40; p < 0.001). El grupo de placebo no mostró cambio significativo alguno en los puntajes global o parcial de EAPP. Además, el grupo de estrógeno potenciado mostró un mejoramiento significativo en tres de ocho ámbitos de SF-36 (dolor de cuerpo, vitalidad y salud mental) y síntomas de depresión (BDI). El grupo de placebo no mostró un mejoramiento significativo a este respecto. Estos resultados demuestran la superioridad del estrógeno potenciado sobre el placebo. Se asociaron pocos eventos adversos con el estrógeno potenciado. Conclusiones: El estrógeno potenciado (12cH, 18cH y 24cH) en dosis de 3 gotas dos veces al día durante 24 semanas fue significativamente más efectivo que el placebo para reducir el dolor pélvico asociado con la endometriosis. Registro del estudio clínico: ClinicalTrials.gov Identificador: https://clinicaltrials.gov/show/NCT02427386.

To evaluate the efficacy and safety of potentized estrogen compared to placebo in homeopathic treatment of endometriosis-associated pelvic pain (EAPP). Study design: The present was a 24-week, randomized, doubleblind, placebocontrolled trial that included 50 women aged 18-45 years old with diagnosis of deeply infiltrating endometriosis based on magnetic resonance imaging or transvaginal ultrasound after bowel preparation, and score ≥ 5 on a visual analogue scale (VAS: range 0 to 10 points) for endometriosis-associated pelvic pain. Potentized estrogen (12cH, 18cH and 24cH) or placebo was administered twice daily per oral route. The primary outcome measure was change in the severity of EAPP global and partial scores (VAS) from baseline to week 24, determined as the difference in the mean score of five modalities of chronic pelvic pain (dysmenorrhea, deep dyspareunia, non-cyclic pelvic pain, cyclic bowel pain and/or cyclic urinary pain). The secondary outcome measures were mean score difference for quality of life assessed with SF-36 Health Survey Questionnaire, depression symptoms on Beck Depression Inventory (BDI), and anxiety symptoms on Beck Anxiety Inventory (BAI). Results: The EAPP global score (VAS: range 0 to 50 points) decreased by 12.82 (p < 0.001) in the group treated with potentized estrogen from baseline to week 24. Group that used potentized estrogen also exhibited partial score (VAS: range 0 to 10 points) reduction in three EAPP modalities: dysmenorrhea (3.28; p < 0.001), non-cyclic pelvic pain (2.71; p = 0.009), and cyclic bowel pain (3.40; p < 0.001). Placebo group did not show any significant changes in EAPP global or partial scores. In addition, the potentized estrogen group showed significant improvement in three of eight SF-36 domains (bodily pain, vitality and mental health) and depression symptoms (BDI). Placebo group showed no significant improvement in this regard. These results demonstrate superiority of potentized estrogen over placebo. Few adverse events were associated with potentized estrogen. Conclusions: Potentized estrogen (12cH, 18cH and 24cH) at a dose of 3 drops twice daily for 24 weeks was significantly more effective than placebo for reducing endometriosis-associated pelvic pain.

Sintoma, sentido e significado a antropologia médica

Aula com Paulo Rosenbaum sobre Sintomas, significado, adoecimento: aspecto da antropologia médica.

Homeopatia na saúde da mulher

A saúde da mulher tem suas fases ao longo do desenvolvimento: a menina, a adolescente, a jovem adulta e a idosa. O tratamento homeopático contempla o tratamento das síndromes que afetam a sua saúde: dismenorreia, distúrbios menstruais, leucorreias, o climatério, sempre buscando compreender seu temperamento, sua individualidade, a forma peculiar de adoecer, a susceptibilidade específica de cada pessoa aos fatores agressores da vida. A consulta em profundidade e o tempo de conversa que a homeopatia preconiza permitem também ao médico homeopata abordar problemas ligados à subjetividade da mulher como o exercício da sexualidade segura, a relação conjugal, sua expressão no mundo, fazendo do momento da consulta, também um diálogo que auxilia a esclarecer os dilemas da vida, a reorientação de condutas e do modo de viver da mulher.

APH: trate-se com Homeopatia

No dia Nacional da Homeopatia trate-se com homeopatia bases dessa maravilhosa terapêutica no âmbito médico, odontológico e na medicina veterinária. Contamos com a presença de: Dra. Ana Patricia Rinaldi Domiciano Dra. Ana Regina Torro Dra. Camila Tais Sperandio Dra. Jussara Giorgi Dra. Mirela Ward

Abordagem homeopática em cuidados paliativos

Live com a Dra. Margarida Haddad. "Cuidados Paliativos” é uma área do cuidado que trata do paciente e da família. E tem um conjunto de orientações e informações claras e diretas que apoiam e facilitam o empenho dos familiares que estão cuidando de parentes doentes. "A experiência de ter alguém doente na família é um tempo único que contribui para o amadurecimento e crescimento pessoal de todos os membros. Aceitação, amor, altruísmo, carinho e homeopatia amenizam todas as dificuldades. O olhar do médico homeopata para o modo peculiar de cada enfermo adoecer e viver sua limitação é imprescindível como terapêutica complementar, permite abrir os olhos e o coração para uma reformulação das concepções de vida mediante a cura da dor profunda ou do impedimento para enxergar a luz da consciência.

Ateneo COVID-19

Ateneo internacional del Departamento de Homeopatía.

Protocolo de Santa Catarina para a Covid-19

Contaremos com a presença das doutoras: Dra. Haydê Haviaras, que é médica Pediatra Homeopata e Presidente da AMHSC. Dra. Marisa Assunta Fantin Ribeiro, que é médica Pediatra e Homeopata, além de professora do Curso de Homeopatia da AMHSC. Dra. Karen Berenice Denez, que é farmacêutica e mestre em assistência farmacêutica pela UFSC, especialista em homeopatia pela ABFH e pela Associação Médica Homeopática do Paraná, além de participar da atual diretoria da ABFH. Dra. Luiza Mara Elias é especialista em cirurgia cardíaca, mestre em ciências médicas pela Universidade Federal de Santa Catarina (UFSC) e professora do Curso de Pós-Graduação em Homeopatia, do CHI (Centro de Homeopatia Integrada) de Florianópolis.

Tratamento médico Homeopático hospitalar Covid-19

#HomeopatiaEmAção recebeu dois ilustres colegas para falarmos sobre COVID-19. Dra. Monica Beier, Médica Homeopata, coordenadora da residência médica de Homeopatia do HPRB Betim e da especialização em Homeopatia do Instituto Mineiro de Homeopatia, que vem nos falar sobre os protocolos de atendimento médico Homeopático hospitalar de pacientes com COVID19. Dr. Francis Mourão - Coordenador do Projeto HOMEOPATIA NA COVID que vem nos atualizar sobre as ações do projeto.

A homeopatia no cuidado das epidemias no SUS de Belo Horizonte

O tema dessa semana é A Homeopatia no cuidado das Epidemias no SUS de Belo Horizonte. Receberemos as as doutoras Cláudia Prass e Valéria Maria Fonseca. Dra Cláudia Prass Santos é médica homeopata referência técnica em Homeopatia da Secretaria Municipal de Saúde de Belo Horizonte e Docente do Serviço Physis de Homeopatia. Dra. Valéria Maria Fonseca médica graduada pela UFJF (Juiz de Fora), em 1979. Especialização em homeopatia pela APH (1980/81), concursada em homeopatia no SUS/PBH desde 1994.

Homeopatia e resposta imune: como a Homeopatia age em nível celular

A AMHB conta com a presença da Profa. Dra. Leoni V. Bonamin, Médica Veterinária, Doutora em Patologia Experimental. Professora Titular da UNIP. Nesta Live, a Dra. Leoni virá abordar experimentos realizados em laboratório com agentes infecciosos para avaliar os parâmetros de resposta imune do medicamento homeopático em células isoladas. Observando assim a célula como um fractal do paciente na sua totalidade e entendendo como a Homeopatia age.

CONABRAH – Congresso Nacional de Homeopatia da ABRAH (Associação Brasileira de Reciclagem e Assistência em Homeopatia)

Reflexões sobre a teoria e a prática da homeopatia em tempos de pandemia

Essa semana a AMHB tem o prazer de receber para a Live #HomeopatiaEmAção uma ilustre figura internacional. Dr. Gustavo Cataldi, Presidente da Liga Médica Homeopática Internacional (LMHI) para abordar o tema: Reflexões sobre a teoria e a prática da homeopatia em tempos de pandemia. Conforme diz o Dr. Cataldi: “A pandemia de Covid-19, mesmo nos países mais desenvolvidos do mundo, não apenas trouxe confusão e caos nos sistemas de saúde pública, como também produziu incertezas sobre a prática e os fundamentos teóricos na comunidade homeopática. Como Presidente da LMHI, desde o início, tenho assistido a informações diferentes vindas de todas as partes mundo, muitas vezes antagônicas. O objetivo desta dissertação é refletir sobre nossa teoria e fornecer a base para a prática correta.” Contaremos com a presença do Presidente da AMHB, Dr. Luiz Darcy Siqueira. Moderadores: Dr. Ariovaldo Ribeiro Filho, Vice-presidente Sudeste da AMHB e Dr. Paulo Maldonado, Vice-presidente para o Brasil da LMHI

Uma proposta de medicina centrada no paciente

A medicina homeopática valoriza o indivíduo em sua forma integral valorizando aspectos ímpares e não somente a hipervalorização de sintomas e hipermedicalização, tratando somente os sintomas, mas sim o ser em sua plenitude. Por isso, medicina centrada no sujeito. Palestra com a Dra. Lilian Ramaldes Vera.

Os segredos da Homeopatia feminina

A mulher é um ser de fases existenciais e ciclos biopsicossociais que muitas vezes dificultam a elas mesmas expressarem para seus médicos homeopatas suas reações. Interpretar estes mistérios e traduzi-los em terapêuticas adequadas é o desafio que discutiremos nesta ocasião. Palestrante: Dr. Eliezer Berenstein e Dra. Helena Las Casas Ralid.

Uma vida dedicada à Homeopatia e à Pediatria

A Dra. Ana Lucia Dias Paulo falará um pouco sobre a sua história e comentará alguns casos de pediatria, em especial, como ela vê a reação de crianças e bebês ao tratamento homeopático. Palestrante: Dra. Ana Lucia Dias Paulo com participação e a Dra. Helena Las Casas Ralid.

Observations on 73 Vaccine breakthrough COVID-19 infected patients and its individualized homeopathic treatment

Since the initiation of vaccine rollout, breakthrough COVID-19 infections have been reported. While conventional therapy is the accepted mode of treatment, there has been little recognition of the role played by the alternative therapies like homeopathy. The purposes of this study were to identify the clinico-symptomatic profile of the vaccine breakthrough covid-19 infections and to assess the response of individualized homoeopathic treatment in these breakthrough cases. A retrospective data analysis of patients treated with homoeopathic medicines who confirmed the breakthrough infection criteria: positive infection ≥14 days after completion of both the recommended doses of an authorized COVID-19 vaccine was conducted. IBM SPSS Statistics 21.0 was used for data analysis with a p-value below 0.05 defined as significant. WHO Clinical Progression Scale and Outcome in Relation to Impact on Daily Living score were used as outcome measures. In total 73 cases were reported to be vaccine breakthrough infections. The median recovery time reported in the data set was 9 ± 2 days. While 5 patients dropped out, 68 (93.15%) patients responded positively to homeopathic treatment, and 55 (75.34%) recovered completely with normalized serological markers/ nasal swabs/ HRCT Chest. About 29 (39.72%) of these presented with mild clinical manifestations, 26 (35.61%) moderate, 17 (23.28%) severe and 1 (1.36%) was critical. 10 homeopathic remedies were prescribed to these 73 patients. Majority of the patients attained an ORIDL score of 4. Maximum patients reported a WHO clinical Progression score of 3. Statistical analysis showed a significant response to homeopathic treatment in the study group. Vaccine breakthrough cases occur in a fraction of vaccinated people. Despite the limited number of study subjects, homoeopathy showed some promising results in the present setup. The response rate was highest in the moderate and severe cases which suggest the importance of consideration of alternative medicine in the current pandemic. Further exploratory research studies and comparative clinical trials may be encouraged.

Optimization of homoeopathy in the management of post-traumatic stress disorder, the aftermath of COVID-19 pandemic: a retrospective case series

Psychological fragility caused to human life has been the largest aftermath of the pandemic posing a raised public health concern globally. This psychological impact is identified as Post-Traumatic Stress Disorder (PTSD) which was the most commonly diagnosed psychological disorder during this pandemic. These cases, if left untreated and unidentified may take a devastating transformation into psychotic disorders and cause gross damage to the individual and the community by disrupting human relations. Keeping in view the beneficial role of Homoeopathy in dealing with psychological disorders based on its philosophy and previous studies, a clinical case series of 10 PTSD cases successfully treated with Homoeopathy during this pandemic are presented here. 10 cases of PTSD consulted during the first wave of pandemic diagnosed based on the clinical picture analogous to PTSD cluster symptomatology from Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) and objectively through Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) were treated with Homoeopathic intervention. Homeopathic medicine was prescribed based on the totality of each case through repertorization and in consultation with the sourcebooks of Homoeopathic Materia Medica (HMM). The cases were followed monthly for clinical improvement and every three months using the CAPS-5 score. The outcome was assessed after six months clinically and objectively through the CAPS-5 score. At the end of one year, further to assess the casual attribution of clinical outcome to homoeopathic intervention, validated MONARCH (Modified Naranjo Criteria for Homoeopathy) tool was utilized. The 10 diagnosed PTSD cases showed marked improvement assessed after one year of Homoeopathic treatment. Significant improvement was found in the clinical picture affirmed through CAPS-5 score and MONARCH tool. Homoeopathic medicines showed a significantly beneficial role in the management of PTSD during the pandemic in the presented 10 cases. Further validation through well-designed clinical trials is warranted.

Lycopodium clavatum as a homeopathic treatment in Magellanic penguins (Sphenicus magellanicus)

Uric acid is the main form of excretion of nitrogenous components in birds. The assessment verification samples, control, check of uric acid concentrations is widely used to detect kidney disease. High concentrations (up to five times) of uric acid in plasma can lead to the precipitation of this acid in the form of crystals, which accumulate in the tissues, mainly in the synovial joints and the viscera surface. Aims: report the evolution of homeopathic treatment in increased uric acid in Magellanic penguins (Spheniscus magellanicus) from Santo André Municipal Zoo. Methodology: 12 animals showed an increase in uric acid (reference values 0,3-16,1mg/dL) and received homeopathic treatment with Lycopodium clavatum 6cH. The protocol established was the administration of two globules of Lycopodium clavatum 6cH, once a day, inside fishes offered in the animal's beak. Treatment started on 25/09/2019. On 30/10/2019 was collected a new blood sample, those who were not discharged were kept on treatment and new collections were made on 27/11/2019 and 17/12/2019. Results: 8 animals had an average uric acid of 20.45mg /dl and responded to the 35-days treatment, normalizing the biochemical values with an average of 12.24mg /dl. Two animals with 18.27 mg /dl were discharged in 62 days with 11.70 mg /dl and another two penguins with 19.85 mg /dl were discharged in 82 days later with 9.57 mg /dl of uric acid. Conclusion: Homeopathy proved to be successful in the treatment of increased uric acid in Magellanic penguins, easy to administer, affordable and without side effects.

Lycopodium as a treatment for Urate Deposition (gout) in birds: case report

A 3-year-old male cockatiel (Nymphicus hollandicus) was diagnosed with joint arthritis due to hyperucemiasyndrome. The bird presented deposition of urate crystals on the synovial membrane with inflammation of joints and tendons (tufts), causing listlessness, anorexia and lameness, with difficulty in keeping perched or moving. Laboratory tests displayed an increase in uric acid and creatinine phosphokinase levels, and leukocytosis despite lymphopenia. Unsucessfully, the animal had been treated with allopathic medicine for 2 months, without a favorable response and still developing stressful reaction to handling.Methodology:High dilution therapy was attempted with 2 globules of Lycopodiumclavatum30 cH /bid and Arnica montana30 cH /bid /oral. The most expressive tufts were removed with daily cleaning of the affected area; a new diet was established and perches were removed, allowing the bird to remain on a flat surface until regression of symptoms. The medication was continued for 30 days. On the second appointment, although the caregiver reported episodes of probable pain, there was an improvement in behavior with normal appetite. Lyc30cH /sid was continued and Arn30cH /bid to qid, depending on pain episodes, for over 30 days. The tutor authorized the case report through a consent form. Results and discussion:Follow-up laboratory tests were performed everythree months for one year, reaching normal levels for uric acid (3.5-11 mg/dL) and CK (30-245mg/dL) on the third measurement. The bird presented no formation of new tufts along the second month of treatment. After 12 months, the animal ingests homeopathic globules spontaneously and presents stable clinical presentation (Lyc30cH / sid / 3 times a week) with no recurrence and without side effects nor stressful behavior. Conclusion: In view of these results, it is considered that homeopathic treatment is an option to be considered in the treatment of joint arthritis from hyperuricemia syndrome in birds.